You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Rich nations, Covid-19 vaccine makers should stop bilateral deals: WHO

WHO chief appealed on Friday to makers of Covid-19 vaccines and the wealthier countries buying them to stop making bilateral deals, saying they hurt a UN-backed effort to widen access to the jabs.

Topics
Coronavirus | Coronavirus Vaccine | World Health Organization

AP  |  Geneva 

Coronavirus, vaccine, vaccination, immunisation, covid, hospital, medical, infra, health, patient
The second nationwide vaccination mock drill was held on Friday at three session sites across 33 states and union territories | Photo: PTI

The World Health Organisation chief appealed on Friday to makers of COVID-19 vaccines and the wealthier countries buying them to stop making bilateral deals, saying they hurt a UN-backed effort to widen access to the jabs.

Tedros Adhanom Ghebreyesus said 42 countries are now rolling out such vaccines, mostly high-income and a few middle-income countries. He called on countries that have more jabs than they need to make some available to the COVAX Facility the UN-backed project to get vaccines deployed widely.

Now, we are also seeing both high- and middle-income countries that are part of COVAX making additional bilateral deals, he told reporters in Geneva. This potentially bumps up the price for everyone and means high-risk people in the poorest and most marginalized countries don't get the vaccine. I urge countries and manufacturers to stop making bilateral deals at the expense of COVAX, said Tedros, the WHO director-general.

Tedros also urged manufacturers to make the data about their vaccines available, which is needed for the U.N. health agency to be able to provide emergency use listings that can expedite their deployment.

The lack of such data blocks the whole system of procurement and delivery, he said.

WHO officials, who generally shun finger-pointing at specific countries and companies that they need to work with, did not specify which ones need to do more to help broaden access to vaccines.

But Canada, for example, is known to have far greater access to vaccines that its population needs. And partners Pfizer and BioNTech, which make the first vaccine that received emergency use approval from the WHO and countries like the U.S. and Britain, have not reached a deal to take part in the COVAX Facility. Dr. Bruce Aylward, a special adviser to the WHO chief, said 50% of high-income countries are deploying vaccines and zero percent of poor countries are.

That is not equitable access, he said. The appeals come as the world has faced high case counts in recent weeks -- roughly 4 million new confirmed infections per week, said WHO emergencies chief Dr. Michael Ryan.

Tedros said some of the highest numbers of deaths recorded at any point in the pandemic have turned up in recent days, and faulted a lack of compliance with recommendations of health authorities. The WHO also said a team of experts who had originally expected to arrive in China this week to look into the origins of the pandemic had not yet arrived, saying that now, we expect to fix the travel dates next week. On Tuesday, Tedros said he was very disappointed that Chinese officials had not finalised the needed permissions for the team's arrival in China.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sat, January 09 2021. 07:47 IST
RECOMMENDED FOR YOU